Defence Therapeutics (DTCFF) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free DTCFF Stock Alerts $0.96 -0.09 (-8.55%) (As of 04/22/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineDefence Therapeutics Signs with German Based FMS Consult GmbH for Financing Strategy to Support Defence Pipeline Growthfinance.yahoo.com - April 17 at 7:50 AMDefence Therapeutics Inc.: Defence Announces Peer-Reviewed Publication on Accum-E7 Anti-Cancer Vaccine in Cancer Science Journal and Financing Updatefinanznachrichten.de - February 29 at 7:55 PMDefence Therapeutics Completes 1st Tranche of Financingfinance.yahoo.com - January 30 at 8:57 PMDefence Financingfinance.yahoo.com - January 19 at 11:43 PMDefence Begins Trading on the OTCQB and Arranges Financingfinance.yahoo.com - January 13 at 12:05 AMDefence Therapeutics Inc DTCFFmorningstar.com - January 10 at 10:12 AMRETRANSMISSION: Defence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)finance.yahoo.com - December 12 at 9:33 AMDefence Receives FDA Approval for Phase I Clinical Trial Targeting Solid Cancer Tumors with AccuTOX(R)finance.yahoo.com - December 11 at 1:24 PMDefence's Successful Submission of an Investigational New Drug (IND) Application for AccuTOX(R) as an Injectable Anticancer Treatment for Solid Tumorsfinance.yahoo.com - November 14 at 8:34 AMDefence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technologyfinance.yahoo.com - November 7 at 8:06 AMDefence Therapeutics Inc.: Defence to Collaborate with Native Ads for Marketing Campaignfinanznachrichten.de - October 27 at 6:06 AMDefence Therapeutics Inc.: Defence to Present Three of Its Leading Products at the Upcoming Festival of Biologics in Basel, Switzerlandfinanznachrichten.de - October 26 at 9:04 PMDefence Therapeutics Inc.: Defence's Accum(R)-mRNA Lipid Nanoparticles Elicit Antibody Response 2X Stronger than Standard mRNA Vaccinesfinanznachrichten.de - October 26 at 4:04 PMDefence's AccuTOX(R) And Antigen Cross-Presentation: Discovery Leads Towards the Development of a Groundbreaking Platformfinance.yahoo.com - October 25 at 8:43 AMDefence Therapeutics Inc (DTC)investing.com - October 22 at 10:01 AMDefence's Novel Accutox(TM) Continues to Surprise on Results Against Cancerfinance.yahoo.com - October 18 at 10:16 AMBristol Myers Squibb Enters the Multi-Billion-Dollar Oncology Racetheglobeandmail.com - October 17 at 11:16 PMDefence's Delivery of Encapsulated AccuTOX(TM)-Chitosan Nanoparticles Triggers Complete Tumor Regression in Animals with Pre-Established Solid Lymphomafinance.yahoo.com - October 17 at 8:14 AMElli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Racetheglobeandmail.com - October 11 at 8:29 AMDefence Announces Peer-reviewed Publication of Its Preclinical Data on Accum(R) as an Anti-Cancer Molecule in the Journal of Cancer Sciencefinance.yahoo.com - October 10 at 8:06 AMDefence to Present Three of Its Leading Products at the Upcoming Festival of Biologics in Basel, Switzerlandfinance.yahoo.com - October 6 at 6:03 PMDefence Therapeutics Inc.: Defence's Innovative Therapeutics Featured on Viewpoint with Dennis Quaidfinanznachrichten.de - September 28 at 7:28 AMDefence's Accum(R)-mRNA Lipid Nanoparticles Elicit Antibody Response 2X Stronger than Standard mRNA Vaccinesfinance.yahoo.com - September 25 at 10:05 AMDefence to Collaborate with Native Ads for Marketing Campaignfinance.yahoo.com - September 22 at 5:53 PMSelf-defense classes for women hit the mark in North Portyahoo.com - September 14 at 5:01 PMDefence's Broad and Versatile Accum(R) Technology Platform Focus on Cancer Therapeuticsfinance.yahoo.com - September 12 at 7:02 AMUkraine's Defence Intelligence chief announces forthcoming attacks in Crimeanews.yahoo.com - September 8 at 6:47 PMDefence Successfully Completes the First Milestone of Its Collaboration Agreement with Oranofinance.yahoo.com - July 18 at 7:41 AMRETRANSMISSION: Defence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnologyfinance.yahoo.com - July 5 at 9:26 AMDefence and Viewpoint with Dennis Quaid Join Forces to Explore Breakthroughs in Biotechnologyfinance.yahoo.com - July 4 at 8:03 AMDefence Therapeutics Inc.: DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESSuk.movies.yahoo.com - June 28 at 12:54 PMDefence Patent Portfolio at the Forefront of Successfinance.yahoo.com - June 28 at 12:54 PMDEFENCE’S PROPRIETARY ACCUM(TM) TECHNOLOGY FOR DELIVERY OF CRISPR/CAS GENOME-EDITING COMPLEXES PATENT APPLICATON PUBLISHEDuk.movies.yahoo.com - June 20 at 10:33 AMDefence Therapeutics Inc.: Defence's Proprietary Accum Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Application Publishedfinanznachrichten.de - June 20 at 10:33 AMDefence's Proprietary Accum(TM) Technology for Delivery of CRISPR/Cas Genome-Editing Complexes Patent Application Publishedfinance.yahoo.com - June 20 at 10:33 AMDTC.MU - Defence Therapeutics Incca.finance.yahoo.com - June 17 at 11:22 PMDTCFF - Defence Therapeutics Inc.ca.finance.yahoo.com - June 17 at 12:27 AMDefence Therapeutics Inc.: Defence Manufacturing of AccuTox CGMP Final Drug Product Optimization for Its Phase I Clinical Trial at City of Hopefinanznachrichten.de - June 16 at 9:26 AMDefence Manufacturing of AccuTox(TM) CGMP Final Drug Product Optimization for Its Phase I Clinical Trial at City of Hopefinance.yahoo.com - June 16 at 9:26 AMDefence Begins Testing Its Arm Vaccine Against Pancreatic Cancerfinance.yahoo.com - June 6 at 7:33 AMDefence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCERuk.news.yahoo.com - June 6 at 2:27 AMDefence Therapeutics Inc.: Defence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Millionfinanznachrichten.de - May 26 at 6:10 PMDefence Announces Additional and Final Exercises of Warrants for Gross Proceeds of Over $2.3 Millionfinance.yahoo.com - May 26 at 6:10 PMDefence Therapeutics Inc.: Defence Granted US Patent with Broad Coverage on Accum-based Vaccine Enhancer Platform Technologyfinanznachrichten.de - May 26 at 1:09 PMDefence Therapeutics Inc.: Breakthrough Results: Defence's Arm Vaccine Cured 100% of Animals with Pre-Established Lymphomafinanznachrichten.de - May 25 at 5:05 PMDefence Therapeutics Inc.: Defence's Novel Accum-mRNA Vaccine Now Administered for Testing on Cancerfinanznachrichten.de - May 25 at 5:05 PMBreakthrough Results: Defence's Arm Vaccine Cured 100% of Animals with Pre-Established Lymphomafinance.yahoo.com - May 24 at 11:01 AMDefence Therapeutics Inc.: DEFENCE’S SUCCESFULL ACCUTOXTM PRE-CLINICAL EFFICACY STUDY COMPLETE READY FOR PHASE I IND FILINGuk.finance.yahoo.com - May 2 at 8:54 AMDefence's Successful AccuTOX(TM) Pre-Clinical Efficacy Study Complete Ready For Phase I IND Filingfinance.yahoo.com - May 2 at 8:54 AMUSPTO Grants Trademark Registration for Defence Therapeutics(R)finance.yahoo.com - April 27 at 7:33 AM Get Defence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DTCFF and its competitors with MarketBeat's FREE daily newsletter. Email Address SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. DTCFF Media Mentions By Week DTCFF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DTCFF News Sentiment▼1.840.48▲Average Medical News Sentiment DTCFF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DTCFF Articles This Week▼11▲DTCFF Articles Average Week Get Defence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DTCFF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DTCFF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Defence Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
